March 26, 2025 Experience SMFG $1.25 billion perpetual subordinated notes offering and tender offers We advised SMFG on its SEC-registered offering of Additional Tier 1 notes and concurrent tender offers
March 26, 2025 Experience China Water Affairs Group CNY1 billion CGIF-guaranteed bonds offering The 3.45% bonds are due 2030
March 25, 2025 Experience Visen Pharmaceutical HK$783.3 million IPO The shares are listed on the HKEX
March 18, 2025 Experience Guotai Junan merger with Haitong and concurrent placement of shares We advised Guotai Junan Securities on the transaction, creating the largest securities company in China
February 26, 2025 Experience iQIYI $350 million convertible notes offering and concurrent private repurchases We advised iQIYI on the transactions
February 18, 2025 Experience Mizuho Financial Group $1.9 billion senior notes offering The offering included fixed-to-fixed reset rate notes and floating-rate notes
January 31, 2025 Experience Kioxia Holdings ¥120.4 billion IPO The shares are listed on the Tokyo Stock Exchange
January 29, 2025 Experience Sanrio ¥135.1 billion secondary offering The shares are listed on the Tokyo Stock Exchange
January 28, 2025 Experience Ascentage Pharma $126.4 million IPO The IPO is the first life sciences U.S. IPO of 2025 and the first life sciences company listed on the HKEX to complete a U.S. listing